Loading…
Satellos Bioscience Inc. is projected to rise to $14.91 by 2027, a +49% move from its current price of $9.99. MSLE is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/2/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 3 | $9.58 | $10.00 | $10.44 | +0.09% |
| Aug 4 | $9.42 | $10.01 | $10.64 | +0.17% |
| Aug 5 | $9.30 | $10.02 | $10.79 | +0.26% |
| Aug 6 | $9.20 | $10.02 | $10.93 | +0.35% |
| Aug 7 | $9.11 | $10.03 | $11.05 | +0.44% |
| Aug 8 | $9.04 | $10.04 | $11.16 | +0.52% |
| Aug 9 | $8.97 | $10.05 | $11.27 | +0.61% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $8.97 | $10.05 | $11.27 | +0.61% |
| Week 2 | $8.61 | $10.11 | $11.88 | +1.23% |
| Week 3 | $8.35 | $10.17 | $12.40 | +1.85% |
| Week 4 | $8.15 | $10.24 | $12.86 | +2.47% |
| Week 5 | $7.98 | $10.30 | $13.29 | +3.10% |
| Week 6 | $7.84 | $10.36 | $13.71 | +3.73% |
| Week 7 | $7.71 | $10.43 | $14.10 | +4.37% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Satellos Bioscience Inc. is a clinical-stage drug development company focused on restoring natural muscle repair and regeneration in degenerative muscle diseases in Canada, the United States, and Australia. It uses its proprietary discovery platform MyoReGenX, an automated microscopy system that recapitulates the muscle stem cell environment ex-vivo.
Satellos develops SAT-3247, an oral, small molecule drug candidate for the treatment of Duchenne muscular dystrophy. The company has a license agreement with the Ottawa Hospital Research Institute (OHRI) and an option agreement with the University of British Columbia. Satellos Bioscience Inc.
was founded in 2018 and is headquartered in Toronto, Canada.
Satellos Bioscience Inc. (MSLE) is a healthcare stock trading at $9.78 per share with a market cap of $203.73M. It is currently ranked 3644 by market capitalization. The near-term outlook is aligned with a neutral to bullish trajectory in the forecast, with 2026 showing an average price of $9.78 and a long-run path toward higher prices, including a 2030 average of $17.81 and a 2050 average of $142.98.
A major floor 58.3% below — a decisive break under it would weaken the trend.
The nearest floor, 43.7% below — buyers have tended to step in here.
Price is pressing into resistance (0.0% away) — a breakout level to watch.
A major ceiling 29.2% above — clearing it would confirm fresh momentum.
Key MSLE support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of MSLE market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $9.59 | Buy | $9.67 | Buy |
| MA 10 | $9.40 | Buy | $9.45 | Buy |
| MA 20 | $9.16 | Buy | $8.99 | Buy |
| MA 50 | $7.59 | Buy | $8.19 | Buy |
| MA 100 | $7.44 | Buy | $7.89 | Buy |
| MA 200 | $7.71 | Buy | $7.57 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 65.95 | Neutral |
| Stoch RSI (14) | 92.73 | Sell |
| CCI (20) | 116.38 | Buy |
| Williams %R (14) | 0.00 | Info |
| MACD (12,26,9) | 0.00 | Buy |
| ROC (12) | 14.17 | Buy |
| Bollinger %B (20,2) | 0.88 | Neutral |
| Stochastic %K (14) | 100.00 | Sell |
| TRIX (15) | 1.20 | Buy |
| Awesome (5,34) | 1.54 | Buy |
| Ultimate (7,14,28) | 60.81 | Neutral |
| Momentum (10) | 1.04 | Buy |
| Aroon Osc (25) | 100.00 | Buy |
| Hull MA (9) | 9.68 | Buy |
| ADX (14) | 26.08 | Buy |
| ATR (14) | 0.31 | Info |
The near-term technical picture is bullish overall. The RSI14 is 70, signaling strong momentum near the upper end of the typical range. The stock trades above both the 50-day and 200-day simple moving averages, with SMA50 at $7.24 and SMA200 at $7.62, supporting a constructive setup.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $5.59 | $9.99 | $14.22 | 0% | Neutral | |
| $11.27 | $14.91 | $21.20 | +49% | Bullish | |
| $10.96 | $15.21 | $22.85 | +52% | Bullish | |
| $11.65 | $16.83 | $26.37 | +69% | Bullish | |
| $14.01 | $20.97 | $34.01 | +110% | Bullish | |
| $16.43 | $25.43 | $42.51 | +155% | Bullish | |
| $21.71 | $34.67 | $59.52 | +247% | Bullish | |
| $24.24 | $39.87 | $70.12 | +299% | Bullish | |
| $25.22 | $42.67 | $76.70 | +327% | Bullish | |
| $25.88 | $45.02 | $82.59 | +351% | Bullish | |
| $42.86 | $84.90 | $169.34 | +750% | Bullish | |
| $94.61 | $210.25 | $472.27 | +20.0x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $5.59 | $9.99 | $11.94 | +0.00% |
| September 2026 | $8.40 | $10.11 | $12.63 | +1.20% |
| October 2026 | $8.89 | $10.82 | $13.73 | +7.00% |
| November 2026 | $8.89 | $10.91 | $14.04 | +0.87% |
| December 2026 | $8.83 | $10.93 | $14.22 | +0.13% |
Click any year to see its month-by-month MSLE forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The MSLE price prediction for 2026 points to an average of $9.99 (low $5.59, high $14.22) — a potential gain of 0% on today's $9.99. Price action looks broadly range-bound.
In 2027, MSLE is projected to trade between $11.27 and $21.20, averaging $14.91 — a potential gain of +49% from today's $9.99. That is up +49% on the projected 2026 average. Buyers look set to stay in control over this stretch.
Satellos Bioscience Inc.'s 2028 outlook centres on $15.21, within a $10.96 to $22.85 range. That is up +2% on the projected 2027 average. That marks a +52% change versus current levels. Momentum favours further upside here.
By 2029, MSLE could reach as high as $26.37, with a base case around $16.83 and support toward $11.65 — roughly +69% from $9.99. Buyers look set to stay in control over this stretch.
Expect MSLE to range from $14.01 to $34.01 through 2030. The $20.97 average target implies a +110% move from current prices. That is up +25% on the projected 2029 average. Momentum favours further upside here.
The MSLE price prediction for 2031 points to an average of $25.43 (low $16.43, high $42.51) — a potential gain of +155% on today's $9.99. Buyers look set to stay in control over this stretch.
In 2032, MSLE is projected to trade between $21.71 and $59.52, averaging $34.67 — a potential gain of +247% from today's $9.99. That is up +36% on the projected 2031 average. Momentum favours further upside here.
Satellos Bioscience Inc.'s 2033 outlook centres on $39.87, within a $24.24 to $70.12 range. That is up +15% on the projected 2032 average. That marks a +299% change versus current levels. Buyers look set to stay in control over this stretch.
By 2034, MSLE could reach as high as $76.70, with a base case around $42.67 and support toward $25.22 — roughly +327% from $9.99. Momentum favours further upside here.
Expect MSLE to range from $25.88 to $82.59 through 2035. The $45.02 average target implies a +351% move from current prices. That is up +6% on the projected 2034 average. Buyers look set to stay in control over this stretch.
The MSLE price prediction for 2040 points to an average of $84.90 (low $42.86, high $169.34) — a potential gain of +750% on today's $9.99. Momentum favours further upside here.
In 2050, MSLE is projected to trade between $94.61 and $472.27, averaging $210.25 — a potential gain of +20.0x from today's $9.99. That is up +148% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in MSLE today (≈ 100.1001 MSLE) could be worth
$21,045.87
+$20,045.87 (+2005%) by 2050 · US Dollar
Based on the average projected MSLE price of $210.25 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in MSLEwould be worth at today's price.
$1,000 invested in MSLE on Jul 31, 2025 (≈ 207.296854 MSLE) would be worth
$2,070.9
+$1,070.9 (+107.1%) today · 2.07× · US Dollar
Based on a MSLE entry price of $4.82 vs. today's $9.99.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $9.78 | $1,021.47 | +2.1% |
| 1 month ago | $7.58 | $1,317.94 | +31.8% |
| 3 months ago | $7.85 | $1,272.61 | +27.3% |
| 6 months ago | $11.62 | $859.58 | -14.0% |
| 1 year ago | $4.82 | $2,070.9 | +107.1% |
| All time (5.0y) ago | $18.72 | $533.65 | -46.6% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our MSLE forecast.
Our base-case forecast reaches $20.00 around 2030.
Implied market cap at $20.00: $416.62M
The multi-year forecast points to substantial upside. In 2030, the average price is projected to $17.81 with a minimum of $11.17 and a maximum of $30.56, for an estimated ROI of 82.1% and a bullish sentiment. By 2040, the average price is projected to $59.10, with a maximum of $127.73 and a minimum of $26.59, for an estimated ROI of 504.3% and a bullish sentiment.
In 2050, the average price is projected to $142.98, with a maximum of $328.86 and a minimum of $64.34, for an estimated ROI of 1362% and a bullish sentiment. These projections reflect a strong long-run upside, though they are estimates and carry the usual uncertainties inherent in forecasting.
Tap a question to reveal the answer.
The 2030 forecast projects an average price of $17.81, a minimum of $11.17, and a maximum of $30.56, with an ROI of 82.1% and a bullish sentiment.
The 2026 forecast shows an average price of $9.78 with an ROI of 0% and a neutral sentiment, while the longer horizon yields bullish sentiment and meaningful upside (2030 avg $17.81; 2050 avg $142.98). These are estimates, not guarantees.
Yes. The 2040 projection shows an average price of $59.10 and a maximum of $127.73, with an ROI of 504.3% and a bullish sentiment, indicating a path that could exceed $60 within the forecast horizon.
The 2026 forecast lists a minimum of $5.59, an average of $9.78, and a maximum of $14.37, with an ROI of 0% and a neutral sentiment.
For 2050, the forecast projects a minimum of $64.34, an average of $142.98, and a maximum of $328.86, with an ROI of 1362% and a bullish sentiment.
Satellos Bioscience Inc. Community Discussion
0Share your Satellos Bioscience Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.